TYME, Inc. logo

TYME, Inc.

Tyme Inc. is a clinical-stage biotechnology company developing cancer therapeutics that are intended to be broadly effective across a range of tumor types, while maintaining patient’s quality of life with relatively low toxicity profiles. Unlike targeted therapies that attempt to regulate specific pathways within cancer, Tyme’s therapeutic approach is designed to take advantage of a cancer cell’s innate metabolic requirements to compromise its defenses, leading to cell death and exposure to the body’s immune system.

[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”TYME” api=”yf” style=”font-size: 15px”]

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttps://www.tymeinc.com
Founded2015
Disease Focus
Development StageClinical
STOCK CODENASDAQ: TYME
Address
44 Wall Street, 12th Floor, NY 10005
New York
United States
Email
Contact Number
+1 646-205 1603

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/tyme-technologies-inc” connections=”true” suffix=””]